1.13 USD
▲0.00+13.00%
盘后 1.03 +2.99%
2026-08-03
市值
$3.44M
市盈率
—
EPS
-7.47
股息率
—
52 周区间
0.97 – 17.95
成交量
195.60K
Beta
1.04
目标价
—
52W 低 0.9752W 高 17.95
价格走势
公司简介
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies ...